This post was originally published on this site I met a guy at a party. At first, he was quite the charmer, one of those middle-aged guys who was the most popular guy in high school. Standing within his orbit, I felt like I’d been invited to join the cool kids’ cafeteria table and everyone…
This post was originally published on this site Targazyme has been granted an award from the The Sexual Medicine Society of North America that will fund a clinical trial testing the company’s stem cell-based product TZ101 to reverse erectile dysfunction in prostate cancer patients. The study will be conducted at The University of Texas Health…
This post was originally published on this site The U.S. Food and Drug Administration is delaying its decision on a new drug application (NDA) seeking approval of selinexor in combination with dexamethasone for patients with multiple myeloma who failed at least three prior therapies. This means that the FDA will decide whether to approve the oral…
This post was originally published on this site A qualitative study has proposed nine recommendations from breast cancer survivors about how to reduce the financial burden associated with the disease, which include changes to insurance, supportive services, financial assistance, and protective policies. The findings of the study, “Patient recommendations for reducing long‐lasting economic burden after…
This post was originally published on this site A new Prostate Cancer Foundation (PCF) collaboration with CURE Media Group, a multimedia platform, is expected to raise awareness of prostate cancer and enhance the scope and availability of disease information. Specifically, the PCF has joined CURE Media’s Strategic Alliance Partnership (SAP) program, which works to cultivate information-sharing…
This post was originally published on this site Novocure has initiated a Phase 3 trial investigating its Tumor Treating Fields (TTFields) — a method that uses electric fields to disrupt cell division — in combination with Taxol (paclitaxel) as a treatment for ovarian cancer patients who are resistant to platinum-based chemotherapy. The trial — which…
This post was originally published on this site An application has been submitted seeking U.S. approval of Darzalex (daratumumab) in combination with standard pre-transplant therapy to treat newly diagnosed multiple myeloma patients who are eligible for a stem cell transplant. Janssen‘s supplemental Biologics License Application to the U.S. Food and Drug Administration (FDA) is for a combination of…
This post was originally published on this site After first rejecting it due to cost-effectiveness concerns, the National Institute for Health and Care Excellence (NICE) has now recommended the use of Adcetris (brentuximab vedotin) as a second-line therapy for patients with CD30-positive cutaneous T-cell lymphomas (CTCL). This means that CTCL patients living in the U.K. may now have access to Adcetris…
This post was originally published on this site Combining anti-PD-L1 immunotherapies with agents that inhibit the DNA damage response (DDR) significantly enhances anti-tumor immunity and leads to rapid tumor disappearance in mouse models of small cell lung cancer (SCLC), a study reports. These preclinical findings suggest that adding DDR inhibitors, such as Lynparza (olaparib) or prexasertib, to immune checkpoint…
This post was originally published on this site Frying oil that has repeatedly been reheated to high temperatures — as can take place in deep frying of foods — may cause genetic changes that trigger the growth and spread of breast cancer, a study in a mouse model of the disease reports. The study, “Thermally…
